Literature DB >> 9756869

Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA.

F M Gribble1, P Proks, B E Corkey, F M Ashcroft.   

Abstract

Insulin secretion from pancreatic beta cells is coupled to cell metabolism through closure of ATP-sensitive potassium (KATP) channels, which comprise Kir6.2 and sulfonylurea receptor (SUR1) subunits. Although metabolic regulation of KATP channel activity is believed to be mediated principally by the adenine nucleotides, other metabolic intermediates, including long chain acyl-CoA esters, may also be involved. We recorded macroscopic and single-channel currents from Xenopus oocytes expressing either Kir6.2/SUR1 or Kir6. 2DeltaC36 (which forms channels in the absence of SUR1). Oleoyl-CoA (1 microM) activated both wild-type Kir6.2/SUR1 and Kir6.2DeltaC36 macroscopic currents, approximately 2-fold, by increasing the number and open probability of Kir6.2/SUR1 and Kir6.2DeltaC36 channels. It was ineffective on the related Kir subunit Kir1.1a. Oleoyl-CoA also impaired channel inhibition by ATP, increasing the Ki values for both Kir6.2/SUR1 and Kir6.2DeltaC36 currents by approximately 3-fold. Our results indicate that activation of KATP channels by oleoyl-CoA results from an interaction with the Kir6.2 subunit, unlike the stimulatory effects of MgADP and diazoxide which are mediated through SUR1. The increased activity and reduced ATP sensitivity of KATP channels by oleoyl-CoA might contribute to the impaired insulin secretion observed in non-insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756869     DOI: 10.1074/jbc.273.41.26383

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Molecular defects in insulin secretion in type-2 diabetes.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 2.  Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes.

Authors:  Michael J Riedel; Diana C Steckley; Peter E Light
Journal:  Hum Genet       Date:  2004-11-23       Impact factor: 4.132

Review 3.  Hypothalamic malonyl-coenzyme A and the control of energy balance.

Authors:  Michael J Wolfgang; M Daniel Lane
Journal:  Mol Endocrinol       Date:  2008-03-20

Review 4.  Metabolic sensing and the brain: who, what, where, and how?

Authors:  Barry E Levin; Christophe Magnan; Ambrose Dunn-Meynell; Christelle Le Foll
Journal:  Endocrinology       Date:  2011-04-26       Impact factor: 4.736

Review 5.  The Pancreatic β-Cell: The Perfect Redox System.

Authors:  Petr Ježek; Blanka Holendová; Martin Jabůrek; Jan Tauber; Andrea Dlasková; Lydie Plecitá-Hlavatá
Journal:  Antioxidants (Basel)       Date:  2021-01-29

6.  Beta oxidation in the brain is required for the effects of non-esterified fatty acids on glucose-induced insulin secretion in rats.

Authors:  C Cruciani-Guglielmacci; A Hervalet; L Douared; N M Sanders; B E Levin; A Ktorza; C Magnan
Journal:  Diabetologia       Date:  2004-11-30       Impact factor: 10.122

Review 7.  Lipid agonism: The PIP2 paradigm of ligand-gated ion channels.

Authors:  Scott B Hansen
Journal:  Biochim Biophys Acta       Date:  2015-01-26

8.  A cytosolic factor that inhibits KATP channels expressed in Xenopus oocytes by impairing Mg-nucleotide activation by SUR1.

Authors:  Paolo Tammaro; Frances M Ashcroft
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

Review 9.  Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator.

Authors:  Jussi Aittoniemi; Constantina Fotinou; Tim J Craig; Heidi de Wet; Peter Proks; Frances M Ashcroft
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

10.  Glucose deprivation regulates KATP channel trafficking via AMP-activated protein kinase in pancreatic beta-cells.

Authors:  Ajin Lim; Sun-Hyun Park; Jong-Woo Sohn; Ju-Hong Jeon; Jae-Hyung Park; Dae-Kyu Song; Suk-Ho Lee; Won-Kyung Ho
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.